Strengthening 340B Program Integrity: What It Means for Providers and Patients
At NPS Pharmacy, we’re deeply committed to both the integrity and sustainability of the 340B Drug Pricing Program — a critical federal program designed to help safety-net providers stretch resources and serve more medically underserved patients.
That’s why we’re proud to share that Christopher Broom, CPhT, 340B ACE, 340B Analyst at NPS Pharmacy, will be a featured panelist in an upcoming webinar hosted by the “Strengthening 340B Program Integrity: Understanding Financial Impact” event page on Thursday, February 26, 2026.
Why 340B Program Integrity Matters
The 340B Program enables eligible hospitals, health centers, and clinics to purchase outpatient drugs at discounted prices, helping them stretch limited budgets and expand care for uninsured, low-income, and vulnerable patients. But as the program grows in scale and complexity, so do the compliance and oversight challenges faced by covered entities.
Recent industry discussions have turned a spotlight on issues like:
Duplicate discounts and Medicaid billing coordination, which can expose programs to compliance risks if not managed properly.
Data accuracy and documentation, given that federal oversight (via HRSA) requires rigorous record-keeping and annual recertification to ensure covered entities are operating within 340B regulations.
The complexity of contract pharmacy relationships and the need for robust internal controls to avoid diversion or misallocation of discounted drugs.
Strengthening program integrity is not about limiting participation — it’s about ensuring the intent of 340B remains focused on expanding access, protecting vulnerable patient populations, and maintaining compliance through sound financial and operational practices.
What the Webinar Will Cover
The Apexus webinar that Christopher will join is part of the Advanced 340B Operations Certificate Program, designed to equip 340B experts with best-in-class knowledge on:
Common accounting methods used in 340B financial reporting
How operational changes affect program finances
Strategies for communicating 340B financial outcomes with internal stakeholders
This practical framework is invaluable for pharmacy professionals and healthcare administrators who are responsible for safeguarding the integrity of their 340B program while maximizing its impact.
Spotlight on Christopher Broom
At NPS Pharmacy, Christopher plays a key role in navigating the complexities of 340B operations — from compliance monitoring to financial analysis. As a 340B Analyst with core expertise in translating pharmacy data into actionable insight, his presence on this panel underscores NPS Pharmacy’s commitment to elevating both operational excellence and patient-centered care.
Christopher’s deep understanding of 340B analytics helps ensure that our team not only meets regulatory expectations but also uses program savings to support meaningful patient outcomes — especially within the communities we serve.
Christopher Broom, CPhT, 340B ACE
Director of Financial Analytics & Data Strategy
